Hypertrophic and Keloid Scar Treatment Market to Grow at a CAGR of 10.6% to reach US$ 9,972.69 Million from 2020 to 2027

report image

Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, and Other Products), and End User (Hospitals, Clinics, and Homecare), and Geography

Publication Month: Jan 2021 | Report Code: TIPRE00007237 | No. of Pages: 197 | Category: Medical Device | Status: Published

The hypertrophic and keloid scar treatment market was valued at US$ 4,498.99 million in 2019 and is projected to reach US$ 9,972.69 million by 2027; it is expected to grow at a CAGR of 10.6% from 2020 to 2027.

A hypertrophic scar refers to a thickened, wide, often raised scar that occurs due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any part of the body; however, the upper chest, shoulders, and upper back are most prone to keloid formation.

The scope of the hypertrophic and keloid scar treatment market includes scar type, product type, end user, and region. The market for hypertrophic and keloid scar treatment, based on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the hypertrophic and keloid scar treatment market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID–19 impact analysis across all the regions. It is estimated that the market is likely to grow at a slower rate in the following years due to the lockdown situations in various countries that have restricted the supply chain of different non-essential medical products. The pandemic has widely affected the aesthetic industry, which has indirectly prohibited scar treatments.

Lucrative Regions for Hypertrophic and Keloid Scar Treatment Market

Lucrative Regions for Hypertrophic and Keloid Scar Treatment Market

Get more information on this report :

Market Insights

Advantages of Laser Treatment

Technological advancements have led to the successful use of laser especially 585 nm PDL, Q-switched 532 nm frequency-doubled Nd: YAG, and CO2 lasers, among other types for treating hypertrophic and keloid scars. The laser treatment helps prevent scar formation after surgery; it reduces pain and itching, and allows movement that is otherwise limited by the scar. The treatment is widely employed to treat hypertrophic and keloid scars caused by burns. According to the “Laser Management of Hypertrophic Burn Scars: a Comprehensive Review,” published in January 2020, burn-related injury follows more than 70% of hypertrophic scars. Similarly, according to the World Health Organization (WHO), burn is the major public health problem. Every year, ~265,000 deaths are registered due to scalds, electrical burns, and other burn forms. Moreover, 90% of the burn incidences are reported in low- and middle-income countries.

As excessive collagen deposition leads to the generation of hypertrophic scars that lead to raised scars, laser treatment proves to be effective against them. Moreover, due to being a minimally invasive method, it ensures reduced scar thickness, pain, and postoperative recovery period. It also helps prevent the need for surgical excision and improves skin pigmentation, pliability, height, pruritus, texture, and heat sensitivity, among other skin conditions of the affected areas. This treatment procedure also proves to be cost-effective, especially for those opting for medical tourism. Owing to such advantages, there is high demand for laser treatment curing hypertrophic and keloid scars.

Scar Type-Based Insights

Based on scar type, the hypertrophic and keloid scar treatment market is bifurcated into hypertrophic and keloid. The hypertrophic segment held a larger share of the market in 2019, as hypertrophic scars are more common. Moreover, these scars do not grow outside the borders of the original wound and eventually grow smaller. Additionally, the treatment for hypertrophic scars typically requires non-invasive procedures such as gels, creams, and silicone sheets in the course of minor injuries and laser treatments. Thus, the segment is estimated to register a higher CAGR in the market during the forecast period.

Global Hypertrophic and Keloid Scar Treatment Market, by Scar Type – 2019 & 2027

Global Hypertrophic and Keloid Scar Treatment Market, by Scar Type – 2019 & 2027

Get more information on this report :

Product Type-Based Insights

Based on product type, the hypertrophic and keloid scar treatment market is segmented into laser products, topical products, injectables, and other products. The injectables segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the hypertrophic and keloid scar treatment market is segmented into hospitals, clinics, and homecare. The hospitals segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Report Coverage - Hypertrophic and Keloid Scar Treatment Market
Report CoverageDetails
Market Size Value inUS$ 4,498.99 Million in 2019
Market Size Value byUS$ 9,972.69 Million by 2027
Growth rateCAGR of 10.6% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages197
No. of Tables138
No. of Charts & Figures80
Historical data availableYes
Segments coveredScar Type , Product Type , and End User , and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Inorganic strategies such as partnerships, and mergers and acquisitions are commonly adopted by companies to cater to changing customer demand and maintain their brand name across the world. Market players operating in the hypertrophic and keloid scar treatment market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.

By Scar Type

  • Hypertrophic
  • Keloid

By Product Type

  • Laser Products
    • CO2
    • Pulse-Dyed
    • Other Laser Products
  • Topical Products
    • Creams
    • Gels
    • Silicone Sheets
    • Other Topical Products
  • Injectables
  • Other Products

By End User

  • Hospitals
  • Clinics
  • Homecare

By

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Alliance Pharma plc
  • Mölnlycke HEALTH CARE AB.
  • Smith & Nephew
  • Newmedical Technology Inc.
  • Rejûvaskin
  • Sonoma Pharmaceuticals, Inc.
  • Suneva Medical
  • HRA Pharma
  • Lumenis
  • Perrigo Company plc.

Frequently Asked Questions

A hypertrophic scar refers to a thickened, wide, often raised scar that occurs due to an injury. A hypertrophic scar usually is an effect of an abnormal response to a trauma or injury. Keloids are reddish nodules that are raised in appearance and develop at the site of an injury. Keloids may occur on any part of the body; however, the upper chest, shoulders, and upper back are most prone to keloid formation.
The growth of the market is attributed to advantages of laser treatment and increasing incidences of injuries. However, unavailability of universal treatment due to high costs, side effects, and scanty awareness hinder the market growth.
The costs of the treatments of these scars are much higher, and they may cost US$ 1,000–5,000, or more, per treatment. The cost may also differ from product to product and treatment cycles.

The List of Companies - Hypertrophic and Keloid Scar Treatment Market

  1. Alliance Pharma plc
  2. Mölnlycke HEALTH CARE AB.
  3. Smith & Nephew
  4. Newmedical Technology Inc.
  5. Rejûvaskin
  6. Sonoma Pharmaceuticals, Inc.
  7. Suneva Medical
  8. HRA Pharma
  9. Lumenis
  10. Perrigo Company plc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hypertrophic and keloid scar treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global hypertrophic and keloid scar treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPRE00007237
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount